ADAR1 Capital Management, LLC 13F holdings, Q3 2024
Holdings as of September 30, 2024 · filings on SEC EDGAR · latest filing →
ADAR1 Capital Management, LLC disclosed 258 US equity positions worth $596.5m in its Q3 2024 13F filing. The largest position was CYTK at 8.1% of the reported book, followed by PTGX and BBIO.
What did ADAR1 Capital Management, LLC own in Q3 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs prior |
|---|---|---|---|---|---|---|---|
| 1 | CYTK CYTOKINETICS INC | Healthcare | 8.1% | $48.1m | 911,182 | – | |
| 2 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 7.4% | $44.2m | 981,295 | – | |
| 3 | BBIO BRIDGEBIO PHARMA INC | Healthcare | 6.2% | $36.9m | 1,448,470 | – | |
| 4 | BOXX EA SERIES TRUST | 5.9% | $35.2m | 323,382 | – | ||
| 5 | ROIV ROIVANT SCIENCES LTD | Healthcare | 5.9% | $34.9m | 3,025,450 | – | |
| 6 | IMVT IMMUNOVANT INC | Healthcare | 5.4% | $32.3m | 1,131,707 | – | |
| 7 | RPRX ROYALTY PHARMA PLC | Healthcare | 5.2% | $31.0m | 1,096,666 | – | |
| 8 | KROS KEROS THERAPEUTICS INC | Healthcare | 4.3% | $25.8m | 445,068 | – | |
| 9 | ASND ASCENDIS PHARMA A/S | Healthcare | 4.0% | $24.1m | 161,402 | – | |
| 10 | ZURA ZURA BIO LTD | Healthcare | 2.6% | $15.3m | 3,770,649 | – | |
| 11 | ZLAB ZAI LAB LTD | Healthcare | 2.2% | $12.9m | 532,454 | – | |
| 12 | KINIKSA PHARMACEUTICALS INTL | 1.8% | $10.9m | 436,668 | – | ||
| 13 | AA MISSION ACQUISITION CORP | 1.7% | $10.1m | 1,010,199 | – | ||
| 14 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 1.5% | $8.8m | 729,401 | – | |
| 15 | ABUS ARBUTUS BIOPHARMA CORP | Healthcare | 1.3% | $8.0m | 2,089,321 | – | |
| 16 | SLDB SOLID BIOSCIENCES INC | Healthcare | 1.3% | $8.0m | 1,145,592 | – | |
| 17 | MERUS N V | 1.3% | $7.7m | 153,286 | – | ||
| 18 | RZLT REZOLUTE INC | 1.3% | $7.6m | 1,571,705 | – | ||
| 19 | PERCEPTIVE CAP SOLUTIONS COR | 1.3% | $7.5m | 750,000 | – | ||
| 20 | XNCR XENCOR INC | Healthcare | 1.2% | $6.9m | 342,262 | – | |
| 21 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 1.1% | $6.7m | 350,206 | – | |
| 22 | ANAB ANAPTYSBIO INC | Healthcare | 1.1% | $6.5m | 192,720 | – | |
| 23 | ABVX ABIVAX SA | 1.0% | $6.0m | 521,612 | – | ||
| 24 | RGNX REGENXBIO INC | Healthcare | 1.0% | $6.0m | 569,008 | – | |
| 25 | BIIB BIOGEN INC | Healthcare | 1.0% | $5.7m | 29,625 | – | |
| 26 | OABI OMNIAB INC | 0.9% | $5.7m | 1,337,302 | – | ||
| 27 | CGON CG ONCOLOGY INC | Healthcare | 0.9% | $5.4m | 143,104 | – | |
| 28 | CRNXGBP CRINETICS PHARMACEUTICALS IN | 0.8% | $4.5m | 88,425 | – | ||
| 29 | HELIX ACQUISITION CORP II | 0.7% | $4.2m | 404,138 | – | ||
| 30 | TECX TECTONIC THERAPEUTIC INC | Healthcare | 0.6% | $3.9m | 127,159 | – | |
| 31 | 2662247D ITEOS THERAPEUTICS INC | 0.6% | $3.8m | 376,737 | – | ||
| 32 | ABSI ABSCI CORPORATION | 0.6% | $3.8m | 1,005,750 | – | ||
| 33 | 0C3 ENDEAVOR GROUP HLDGS INC | 0.6% | $3.5m | 122,807 | – | ||
| 34 | APGE APOGEE THERAPEUTICS INC | Healthcare | 0.6% | $3.4m | 57,183 | – | |
| 35 | DNTH DIANTHUS THERAPEUTICS INC | Healthcare | 0.5% | $3.3m | 118,738 | – | |
| 36 | SVRA SAVARA INC | Healthcare | 0.5% | $3.1m | 742,634 | – | |
| 37 | DNLI DENALI THERAPEUTICS INC | Healthcare | 0.5% | $3.0m | 101,826 | – | |
| 38 | GRCE ACASTI PHARMA INC | 0.5% | $2.9m | 959,571 | – | ||
| 39 | QTTB Q32 BIO INC | 0.5% | $2.9m | 64,245 | – | ||
| 40 | PLRX PLIANT THERAPEUTICS INC | Healthcare | 0.5% | $2.8m | 246,128 | – | |
| 41 | GERN GERON CORP | Healthcare | 0.4% | $2.5m | 557,159 | – | |
| 42 | PIERIS PHARMACEUTICALS INC | 0.4% | $2.4m | 144,641 | – | ||
| 43 | VIR VIR BIOTECHNOLOGY INC | Healthcare | 0.4% | $2.4m | 319,185 | – | |
| 44 | CLRB CELLECTAR BIOSCIENCES INC | 0.4% | $2.2m | 1,022,161 | – | ||
| 45 | ALKS ALKERMES PLC | Healthcare | 0.3% | $2.1m | 74,431 | – | |
| 46 | RVMD REVOLUTION MEDICINES INC | Healthcare | 0.3% | $2.0m | 44,351 | – | |
| 47 | BIL SPDR SER TR | 0.3% | $2.0m | 21,786 | – | ||
| 48 | ALEC ALECTOR INC | Healthcare | 0.3% | $2.0m | 428,802 | – | |
| 49 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 0.3% | $1.9m | 108,171 | – | |
| 50 | KALA KALA BIO INC | 0.3% | $1.7m | 306,067 | – |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.